Trevi Therapeutics, Inc. TRVI Cash received from option exercises
Cash received from option exercises at other companies
Other financials
Where this comes from
Reported directly by Trevi Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromStockOptionsExercised.
The official record: Trevi Therapeutics, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →
Ask your AI about Trevi Therapeutics, Inc.'s cash received from option exercises.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Trevi Therapeutics, Inc.'s cash received from option exercises?
- Trevi Therapeutics, Inc. (TRVI) reported cash received from option exercises of $222K in Q1 2026.
- How has Trevi Therapeutics, Inc.'s cash received from option exercises changed year-over-year?
- Trevi Therapeutics, Inc.'s cash received from option exercises decreased by 69.1% year-over-year, from $718K to $222K.
- What is the long-term trend for Trevi Therapeutics, Inc.'s cash received from option exercises?
- Over 3 years (2022 to 2025), Trevi Therapeutics, Inc.'s cash received from option exercises has grown at a 146.4% compound annual growth rate (CAGR), from $139K to $2.08M.
- What does cash received from option exercises mean?
- Represents the cash received from employees or directors exercising their vested stock options. This metric reflects the conversion of equity-based compensation into cash and indicates the level of participation in employee stock incentive programs.